Skip to main content

Want a detailed portfolio tracker?

SCNX
NASDAQ
$0.42

Scienture Holdings Inc (SCNX)

Scienture Holdings, Inc. (SCNX) is a pioneering biotechnology firm focused on transforming the treatment landscape for neurological disorders through its advanced drug development pipeline and a seasoned research team. The company is dedicated to addressing significant unmet medical needs, highlighting its potential to enhance patient outcomes while skillfully navigating regulatory complexities. With a strong emphasis on scientific integrity and strategic collaborations, Scienture is well-positioned to leverage growth opportunities in the burgeoning global healthcare market, particularly as the demand for effective neurological therapies continues to rise.
Website: https://scienture.com
68 analysts
Strong Buy
Target: $1.50 (+260.58%)

Market Cap

$17M

P/B Ratio

0.24

EPS 5Y CAGR

+90.01%

FCF 5Y CAGR

+43.21%

Price Chart

Valuation
Market Cap$17M
Forward P/E21.83
P/S34.70
P/B0.24
Profitability
Total Revenue (TTM)$478K
Gross Profit (TTM)$385K
EBITDA-$42M
Operating Margin-6231%
EPS-$1.35
Financial Health
Free Cash Flow Yield-80.49%
Growth & Risk
EPS 5Y CAGR+90.01%
Revenue 5Y CAGR-51.59%
FCF 5Y CAGR+43.21%
Beta (5Y)1.82
Sharpe Ratio0.31